Orchid Pharma Limited Strategic Asset Allocation Index
Orchid Pharma Limited strategic asset allocation index. Orchid Pharma Limited (ORCHPHARMA) has a Strategic Asset Allocation Index of 99.0% as of September 2022. Strategic assets (PP&E of Rs6.16 Billion plus long-term investments of Rs-) total Rs6.16 Billion, measured against net assets of Rs6.22 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check ORCHPHARMA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Orchid Pharma Limited (2020–2022)
Strategic asset allocation index of Orchid Pharma Limited from 2020 to 2022. This chart shows how Orchid Pharma Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 99.0%, representing strategic assets of Rs6.16 Billion against net assets of Rs6.22 Billion INR.
Orchid Pharma Limited Strategic Asset Allocation Index by Year (2020–2022)
Orchid Pharma Limited strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Orchid Pharma Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ORCHPHARMA market cap.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 91.6% | Rs5.93 Billion | Rs5.93 Billion | Rs- | Rs6.47 Billion | ▼ -12.1 pp |
| 2021 | 103.8% | Rs6.78 Billion | Rs6.78 Billion | Rs- | Rs6.53 Billion | ▼ -8.3 pp |
| 2020 | 112.1% | Rs8.59 Billion | Rs8.59 Billion | Rs- | Rs7.66 Billion | — |